SREBF1 and Disorder of lipid metabolism: These results suggest that TLSP exerts lipid-lowering and antiobesity effects by inhibiting PPARγ2 and the SREBP-1 pathway and may be an efficacious therapeutic agent to prevent lipid metabolic disorder and regulate adipocyte differentiation and proliferation.